Your browser doesn't support javascript.
loading
The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.
Epis, Michael R; Barker, Andrew; Giles, Keith M; Beveridge, Dianne J; Leedman, Peter J.
Afiliação
  • Epis MR; Laboratory for Cancer Medicine, Western Australian Institute for Medical Research and University of Western Australia Centre for Medical Research, Royal Perth Hospital, Perth, Western Australia 6000, Australia.
  • Barker A; Laboratory for Cancer Medicine, Western Australian Institute for Medical Research and University of Western Australia Centre for Medical Research, Royal Perth Hospital, Perth, Western Australia 6000, Australia.
  • Giles KM; Laboratory for Cancer Medicine, Western Australian Institute for Medical Research and University of Western Australia Centre for Medical Research, Royal Perth Hospital, Perth, Western Australia 6000, Australia.
  • Beveridge DJ; Laboratory for Cancer Medicine, Western Australian Institute for Medical Research and University of Western Australia Centre for Medical Research, Royal Perth Hospital, Perth, Western Australia 6000, Australia.
  • Leedman PJ; Laboratory for Cancer Medicine, Western Australian Institute for Medical Research and University of Western Australia Centre for Medical Research, Royal Perth Hospital, Perth, Western Australia 6000, Australia; School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western A
J Biol Chem ; 286(48): 41442-41454, 2011 Dec 02.
Article em En | MEDLINE | ID: mdl-21971048
ABSTRACT
ERBB-2 overexpression is associated with the development and progression of cancer and mediates its resistance to therapy. It has been suggested that post-transcriptional mechanisms control the overexpression of ERBB-2 in prostate cancer (PCa). We recently demonstrated that the 3'-untranslated region (3'-UTR) of ERBB-2 mRNA contains two specific target sites for binding of the microRNA miR-331-3p and that miR-331-3p represses ERBB-2 expression and signaling in PCa cells. Here we investigate a U-rich element situated in close proximity to the distal miR-331-3p target site in the ERBB-2 3'-UTR. Specific binding of HuR to this U-rich element promotes ERBB-2 expression in PCa cells. We show that HuR antagonizes the repressive action of miR-331-3p on its distal ERBB-2 3'-UTR target site. These results support a model in which the interplay between RNA-binding proteins and microRNAs controls the post-transcriptional regulation of gene expression and suggest that both HuR and miR-331-3p participate in the overexpression of ERBB-2 observed in some PCas.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / RNA Neoplásico / Regulação Neoplásica da Expressão Gênica / Receptor ErbB-2 / MicroRNAs / Proteínas ELAV Limite: Humans / Male Idioma: En Revista: J Biol Chem Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / RNA Neoplásico / Regulação Neoplásica da Expressão Gênica / Receptor ErbB-2 / MicroRNAs / Proteínas ELAV Limite: Humans / Male Idioma: En Revista: J Biol Chem Ano de publicação: 2011 Tipo de documento: Article País de afiliação: Austrália